Loretta D'Onofrio Selected Research

Loretta D'Onofrio Research Topics

10	Breast Neoplasms (Breast Cancer) 11/2020 - 09/2015
6	Neoplasms (Cancer) 11/2020 - 12/2011
1	Obesity 11/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Hyperglycemia 01/2017
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2016
1	Hypercalcemia (Milk Alkali Syndrome) 09/2015
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2015
1	Pancreatitis 05/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2015
1	Male Breast Neoplasms (Male Breast Cancer) 07/2014
1	Sarcoma (Soft Tissue Sarcoma) 12/2011
1	Rare Diseases (Rare Disease) 12/2011
1	Carcinogenesis 12/2011

4	pertuzumabIBA 11/2020 - 01/2017
2	Ado-Trastuzumab EmtansineIBA 11/2020 - 01/2017
2	Diphosphonates (Bisphosphonates)IBA 11/2020 - 09/2015
2	eribulin FDA Link 11/2019 - 04/2017
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 04/2016
2	Antineoplastic Agents (Antineoplastics)IBA 09/2015 - 02/2015
1	Denosumab FDA Link 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	Taxoids (Taxanes)IBA 01/2019
1	taxaneIBA 01/2019
1	exemestane (Aromasin)FDA Link 01/2017
1	Everolimus FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Phenobarbital (Luminal)FDA Link 04/2016
1	pazopanib FDA Link 05/2015
1	Tyrosine Kinase InhibitorsIBA 05/2015
1	Amylases FDA Link 05/2015
1	Lipase (Acid Lipase)FDA Link 05/2015
1	Nicotine FDA Link 05/2013
1	MTOR InhibitorsIBA 12/2011
1	TOR Serine-Threonine KinasesIBA 12/2011